Back

Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease.

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Special populations Paediatric Cardiology ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Kenji Hamaoka

Kyoto Prefectural University of Medicine, Kyoto (Japan)

11 More presentations in this session

Presentation thumbnail
Doctor T. Aikawa (Tokyo, JP)
Abstract
Presentation thumbnail
Professor K. Sliwa (Cape Town, ZA)
Presentation thumbnail
Ms J. Therkildsen (Herning, DK)
Abstract
Presentation thumbnail
Doctor I. Kanakakis (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor F. Macaya Ten (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Special populations

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Role of spleen tyrosine kinase (Syk) in pathogenesis of aortic dissection.
29 August 2025
thumbnail
Congress Presentation
Normal myocardial perfusion in kawasaki disease convalescence: an age, body-surface-area and sex-matched analysis using fully automated quantitative stress perfusion cardiac MRI.
30 August 2025
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice
30 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources